Aurobindo Pharma Acquires US Step-Down Subsidiary A1 Biochem Labs LLC

Aurobindo Pharma Ltd, through its wholly owned subsidiary Apitoria Pharma Private Limited, has acquired 100% ownership of A1 Biochem Labs LLC (A1 Labs LLC) in the USA. A1 Labs LLC, based in Wilmington, North Carolina, provides contract research and chemistry services to pharmaceutical and biotechnology companies. The acquisition aligns with Aurobindo Pharma's strategy to expand its Active Pharmaceutical Ingredients (API) business and create a dedicated Contract Research, Development and Manufacturing (CRDMO) platform. A1 Labs LLC reported sales of USD 9.23 Million in CY2024 and USD 5.92 Million in CY2025. The transaction is considered a related party transaction as A1 Labs LLC is being acquired from Dr. Rajendra Gadikota, a Director of A1 Labs India, but is being undertaken at arm's length. No governmental or regulatory approvals are required for this acquisition.